Top-Rated Stocks NASDAQ:GH Guardant Health - GH Short Interest Ratio & Short Volume Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $23.57 +0.65 (+2.84%) (As of 03/31/2023 11:22 AM ET) Add Compare Share Share Today's Range$23.12▼$23.8850-Day Range$22.92▼$33.7652-Week Range$22.39▼$77.72Volume501,039 shsAverage Volume2.00 million shsMarket Capitalization$2.42 billionP/E RatioN/ADividend YieldN/APrice Target$57.64 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Guardant Health Short Interest DataCurrent Short Volume6,310,000 sharesPrevious Short Volume7,000,000 sharesChange Vs. Previous Month-9.86%Dollar Volume Sold Short$168.98 millionShort Interest Ratio / Days to Cover3.1Last Record DateMarch 15, 2023Outstanding Shares102,660,000 sharesFloat Size97,700,000 sharesShort Percent of Float6.46%Today's Trading Volume501,039 sharesAverage Trading Volume1,995,877 sharesToday's Volume Vs. Average-74.90% Short Selling Guardant Health ? Sign up to receive the latest short interest report for Guardant Health and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGH Short Interest Over TimeGH Days to Cover Over TimeGH Percentage of Float Shorted Over Time Guardant Health (NASDAQ:GH) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20236,310,000 shares $168.98 million -9.9%6.5%3.1 $26.78 2/28/20237,000,000 shares $216.23 million +13.1%7.2%3.4 $30.89 2/15/20236,190,000 shares $179.32 million +11.9%6.3%3.2 $28.97 1/31/20235,530,000 shares $173.81 million -0.4%6.1%3.3 $31.43 1/15/20235,550,000 shares $168.89 million +8.8%5.7%3.5 $30.43 12/30/20225,100,000 shares $138.72 million +18.9%5.3%3.3 $27.20 12/15/20224,290,000 shares $177.01 million +3.9%4.4%3.1 $41.26 11/30/20224,130,000 shares $216.16 million -1.9%4.3%4.1 $52.34 11/15/20224,210,000 shares $215.76 million +5.5%4.4%4.1 $51.25 10/31/20223,990,000 shares $197.51 million +1.8%4.1%4 $49.50 10/15/20223,920,000 shares $191.14 million +4.3%4.1%4 $48.76 9/30/20223,760,000 shares $202.40 million -12.2%3.9%4.1 $53.83 9/15/20224,280,000 shares $252.05 million -7.2%4.5%4.6 $58.89 8/31/20224,610,000 shares $230.78 million +3.1%4.8%4.5 $50.06 8/15/20224,470,000 shares $246.03 million +5.9%4.6%4 $55.04 7/31/20224,220,000 shares $211.72 million +7.9%4.4%2.9 $50.17 7/15/20223,910,000 shares $190.46 million -2.3%4.1%2.6 $48.71 6/30/20224,000,000 shares $161.36 million -7.2%4.2%2.8 $40.34 6/15/20224,310,000 shares $165.59 million +7.5%4.5%3 $38.42 5/31/20224,010,000 shares $164.33 million +16.2%4.2%2.9 $40.98 5/15/20223,450,000 shares $123.89 million -11.8%3.6%2.5 $35.91 4/30/20223,910,000 shares $241.25 million +3.2%4.1%3.5 $61.70 4/15/20223,790,000 shares $272.84 million +0.8%4.0%3.6 $71.99 3/31/20223,760,000 shares $249.06 million -1.1%N/A0 $66.24 3/15/20223,800,000 shares $185.29 million -1.8%4.0%3.3 $48.76 2/28/20223,870,000 shares $256.46 million +13.2%4.1%3.3 $66.27 2/15/20223,420,000 shares $247.54 million -15.6%3.6%2.8 $72.38 1/31/20224,050,000 shares $281.68 million -4.5%4.3%3.3 $69.55 1/15/20224,240,000 shares $328.94 million +0.7%N/A3.6 $77.58 12/31/20214,210,000 shares $421.08 million -12.3%4.4%4 $100.02 12/15/20214,800,000 shares $463.39 million +11.4%5.1%4.3 $96.54 11/30/20214,310,000 shares $453.07 million +8.8%4.5%4.2 $105.12 11/15/20213,960,000 shares $410.45 million +5.9%4.2%4 $103.65 10/29/20213,740,000 shares $436.79 million -13.0%3.9%4.1 $116.79 10/15/20214,300,000 shares $436.88 million -7.1%4.5%4.7 $101.60 9/30/20214,630,000 shares $578.80 million +7.2%4.9%5.2 $125.01 9/15/20214,320,000 shares $548.64 million +3.4%4.6%5.5 $127.00 8/31/20214,180,000 shares $531.99 million +9.7%4.4%4.8 $127.27 8/13/20213,810,000 shares $385.88 million +16.2%4.0%4.3 $101.28 7/30/20213,280,000 shares $360.14 million -4.4%3.4%3.4 $109.80 GH Short Interest - Frequently Asked Questions What is Guardant Health's current short interest? Short interest is the volume of Guardant Health shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 6,310,000 shares of GH short. 6.46% of Guardant Health's shares are currently sold short. Learn More on Guardant Health's current short interest. What is a good short interest ratio for Guardant Health? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GH shares currently have a short interest ratio of 3.0. Learn More on Guardant Health's short interest ratio. Which institutional investors are shorting Guardant Health? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Guardant Health: Parallax Volatility Advisers L.P., Portman Square Capital LLP, Jane Street Group LLC, Jefferies Financial Group Inc., Point72 Asset Management L.P., Susquehanna International Group LLP, Twin Tree Management LP, JPMorgan Chase & Co., Group One Trading L.P., Cowen AND Company LLC, Cutler Group LLC CA, Simplex Trading LLC, Wolverine Asset Management LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Guardant Health? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.46% of Guardant Health's floating shares are currently sold short. Is Guardant Health's short interest increasing or decreasing? Guardant Health saw a decline in short interest during the month of March. As of March 15th, there was short interest totaling 6,310,000 shares, a decline of 9.9% from the previous total of 7,000,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Guardant Health's float size? Guardant Health currently has issued a total of 102,660,000 shares. Some of Guardant Health's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Guardant Health currently has a public float of 97,700,000 shares. How does Guardant Health's short interest compare to its competitors? 6.46% of Guardant Health's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Guardant Health: Veracyte, Inc. (5.52%), RadNet, Inc. (2.90%), Viridian Therapeutics, Inc. (6.48%), Fulgent Genetics, Inc. (6.20%), Natera, Inc. (5.33%), TransMedics Group, Inc. (5.03%), Amedisys, Inc. (5.65%), Pacific Biosciences of California, Inc. (10.64%), Galapagos NV (2.25%), and Glaukos Co. (10.58%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short Guardant Health stock? Short selling GH is an investing strategy that aims to generate trading profit from Guardant Health as its price is falling. GH shares are trading up $0.65 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Guardant Health? A short squeeze for Guardant Health occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GH, which in turn drives the price of the stock up even further. How often is Guardant Health's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GH, twice per month. The most recent reporting period available is March, 15 2023. More Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GH) was last updated on 3/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.